Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pediatrix Medical (MD) Short-Term Debt issuances (2016 - 2024)

Pediatrix Medical (MD) has disclosed Short-Term Debt issuances for 15 consecutive years, with $65.0 million as the latest value for Q2 2024.

  • Quarterly Short-Term Debt issuances fell 68.29% to $65.0 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $65.0 million through Mar 2025, down 84.69% year-over-year, with the annual reading at $235.5 million for FY2024, 49.89% down from the prior year.
  • Short-Term Debt issuances for Q2 2024 was $65.0 million at Pediatrix Medical, down from $170.5 million in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $515.0 million in Q1 2020, with the low at $12.5 million in Q2 2020.
  • Average Short-Term Debt issuances over 4 years is $187.5 million, with a median of $199.5 million recorded in 2022.
  • Peak annual rise in Short-Term Debt issuances hit 0.68% in 2020, while the deepest fall reached 96.71% in 2020.
  • Over 4 years, Short-Term Debt issuances stood at $12.5 million in 2020, then skyrocketed by 1144.0% to $155.5 million in 2022, then plummeted by 68.49% to $49.0 million in 2023, then soared by 32.65% to $65.0 million in 2024.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at $65.0 million, $170.5 million, and $49.0 million for Q2 2024, Q1 2024, and Q3 2023 respectively.